Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05377190
Other study ID # 2022-10426
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 8, 2022
Est. completion date June 2024

Study information

Verified date April 2023
Source Centre hospitalier de l'Université de Montréal (CHUM)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Heart failure (HF) is one of the leading causes of hospitalization and death worldwide. Remote patient monitoring and digital therapeutics could help reduce the consumption of care for these patients (hospitalizations, emergency room visits) and optimize their management (education, medication optimization). This randomized study aims to evaluate the effects of the Continuum software solution in patients with heart failure, whether or not they are followed in specialized clinics. Heart failure is one of the main causes of hospitalization and death in the world. Evidence suggests that remote patient monitoring (RPM) and digital therapeutics (DTX solutions) can help improve care consumption (i.e. hospitalizations, emergency visits) and also support health care professionals to improve care (i.e. symptoms management, drug optimization). This randomised study aims to evaluate the effects of these two software solutions in the context of specialized HF clinics (HFC) and primary health care on health care consumption and clinical events.


Description:

According to Canadian recommendations, patients recently diagnosed with heart failure or with a recent hospitalization should have a medical follow-up every two to four weeks in order to optimize their treatment and quickly stabilize their condition. However, despite a network of specialized heart failure clinics in the province of Quebec, access to this service is still a challenge because of limited human resources and unequal geographic distribution. Only the most severely ill and unstable patients are followed in these clinics. The Continuum project combines a remote patient monitoring solution with therapeutic interventions driven by a software to manage heart failure (also called digital therapeutics (DTx)). The patient can send her/his clinical data to the healthcare professional using a mobile application. Healthcare professionals receive not only these data in realtime with potential alerts but also a summarized report of these data and suggested therapeutic interventions. Our hypotheses are that the Continuum solution, by combining RPM and DTx will 1) improve the workflow and the care trajectory of patients in heart failure clinics resulting in a reduction of cost per patient followed and 2) accelerate drug optimization so they can fully benefit from the recommended therapies for their specific condition. The general objective of this project is to assess in outpatients the effectiveness of the Continuum solution to reduce healthcare costs and to support medication optimization over a period of 12 weeks.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 400
Est. completion date June 2024
Est. primary completion date March 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility HFC-IN Inclusion Criteria: - HF diagnostic - NYHA 2 or + - Active follow-up in heart failure clinic - Ability to use mobile app (or with caregiver's help) - And one of the following - New HF diagnosis (<3 months) - Emergency visit or recent hospitalization with decompensated HF (<6months) - Increase of >50% diuretic dose, new diuretic or IV diuretic (last 3 months) - Active heart failure follow-up 2 times in the last 3 months HFC-OUT Inclusion Criteria: - HF diagnostic - Ability to use mobile app (or with caregiver's help) - No active follow-up in heart failure clinic or in the waiting list of one Exclusion Criteria for HFC-IN and HFC-OUT: - Active hospitalization at randomization or anticipated in the next 2 weeks - Incapable or minor patient - History of non-adherence or treatment refusal - Alcohol or drugs abuse - Active major depression without caregiver - Global prognosis < 3months - Active dialysis or on waiting list - Heart transplant or mechanical heart - Severe pulmonary disease with oxygen use or pulmonary transplant waiting list or recurrent pleural drainage - Severe chronic cirrhosis or hepatic transplant waiting list or recurrent ascites drainage - Percutaneous or surgical intervention in last 30 days or planned in next 3 months - Pregnancy - Active follow-up in another study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Continuum HFC-IN
Combination of a mobile application (with remote monitoring) and digital therapeutics
Standard of care for the follow-up
No mobile application or digital therapeutics are used
Continuum HFC-OUT
Combination of a mobile application (without remote monitoring) and digital therapeutics

Locations

Country Name City State
Canada CRCHUM Montréal Quebec

Sponsors (3)

Lead Sponsor Collaborator
Centre hospitalier de l'Université de Montréal (CHUM) Boehringer Ingelheim, Greybox

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary CLIC IN ONLY: care consumption Cost analysis on number of hospital (planned or unplanned) ambulatory visits, emergency visits, consultations and hospitalizations 12 weeks
Primary CLIC OUT ONLY: Change in guideline-directed medical therapy by classes Change in guideline-directed medical Therapy optimization between groups before and after intervention by medication classes. 12 weeks
Primary CLIC OUT ONLY: Change in guideline-directed medical therapy by dose Change in guideline-Directed Medical Therapy optimization between groups before and after intervention by medication doses. 12 weeks
Secondary CLIC OUT ONLY: Care consumption Cost analysis on number of hospital (planned or unplanned) ambulatory visits, emergency visits, consultations and hospitalizations during intervention 12 weeks
Secondary CLIC IN ONLY: Change in guideline-directed medical therapy by classes Compare guideline-Directed Medical Therapy optimization between groups before and after intervention by medication classes 12 weeks
Secondary CLIC IN ONLY: Change in guideline-directed medical therapy by doses Compare guideline-Directed Medical Therapy optimization between groups before and after intervention by medication doses 12 weeks
Secondary MACE and other clinical events Differences before-after between groups in number of main clinical events including unplanned appointments, emergency consults, all-cause or heart-failure hospitalizations, deaths 12 weeks
Secondary CLIC IN ONLY: Quality of life assessment (QoL) with the Kansas City Cardiomyopathy Questionnaire Differences in score before and after 12 weeks
Secondary Quality of life assessment (QoL) with the EQ-5D-5L EuroQOL instrument Differences in score before and after 12 weeks
Secondary New York Heart Association class A reduction of at least one class in New York Heart Association (NYHA) scale 12 weeks
Secondary NTproBNP Reduction in NTproBNP greater than 30% 12 weeks
Secondary Pharmacological profile Percentage of recommended heart failure drugs prescribed 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy